These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21392671)

  • 1. Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats.
    Fujita Y; Watanabe K; Uchikanbori S; Maki K
    Am J Orthod Dentofacial Orthop; 2011 Mar; 139(3):e267-77. PubMed ID: 21392671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term etidronate treatment prevents glucocorticoid-induced bone debility of the mandible in growing rats.
    Fujita Y; Konoo T; Maki K
    Orthod Craniofac Res; 2008 Nov; 11(4):187-95. PubMed ID: 18950314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
    Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
    Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
    Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zordan S; Sella S; Fassina A; Turco G; Realdi G; Lo Cascio V; Giannini S
    J Endocrinol Invest; 2007 Oct; 30(9):739-46. PubMed ID: 17993765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risedronate reduces intracortical porosity in women with osteoporosis.
    Borah B; Dufresne T; Nurre J; Phipps R; Chmielewski P; Wagner L; Lundy M; Bouxsein M; Zebaze R; Seeman E
    J Bone Miner Res; 2010 Jan; 25(1):41-7. PubMed ID: 19580469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats.
    Cetinkaya BO; Keles GC; Ayas B; Gurgor P
    J Periodontol; 2008 Oct; 79(10):1950-61. PubMed ID: 18834251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bisphosphonate on the mandible of rats in the growing phase with steroid-induced osteoporosis.
    Kimura E; Nishioka T; Hasegawa K; Maki K
    Oral Dis; 2007 Nov; 13(6):544-9. PubMed ID: 17944670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.
    Chevalier Y; Quek E; Borah B; Gross G; Stewart J; Lang T; Zysset P
    Bone; 2010 Jan; 46(1):41-8. PubMed ID: 19800436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
    Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K
    J Rheumatol; 2008 Mar; 35(3):407-13. PubMed ID: 18260178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone.
    Hunziker J; Wronski TJ; Miller SC
    J Dent Res; 2000 Jun; 79(6):1431-8. PubMed ID: 10890724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The skeletal effects of glucocorticoid excess override those of orchidectomy in mice.
    Weinstein RS; Jia D; Powers CC; Stewart SA; Jilka RL; Parfitt AM; Manolagas SC
    Endocrinology; 2004 Apr; 145(4):1980-7. PubMed ID: 14715712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover.
    Borah B; Ritman EL; Dufresne TE; Jorgensen SM; Liu S; Sacha J; Phipps RJ; Turner RT
    Bone; 2005 Jul; 37(1):1-9. PubMed ID: 15894527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).
    Fujii N; Hamano T; Mikami S; Nagasawa Y; Isaka Y; Moriyama T; Horio M; Imai E; Hori M; Ito T
    Nephrol Dial Transplant; 2007 Jun; 22(6):1601-7. PubMed ID: 17124283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization.
    Yao W; Cheng Z; Pham A; Busse C; Zimmermann EA; Ritchie RO; Lane NE
    Arthritis Rheum; 2008 Nov; 58(11):3485-97. PubMed ID: 18975341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral ipriflavone on the rat mandible during growth.
    Maki K; Nishida I; Kimura M
    Eur J Orthod; 2005 Feb; 27(1):27-31. PubMed ID: 15743860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
    Gasser JA; Green JR; Shen V; Ingold P; Rebmann A; Bhatnagar AS; Evans DB
    Bone; 2006 Oct; 39(4):787-95. PubMed ID: 16844441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.
    Ito M; Nakayama K; Konaka A; Sakata K; Ikeda K; Maruyama T
    Bone; 2006 Sep; 39(3):453-9. PubMed ID: 16581323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.